Skip to main content

Market Overview

BIOLASE, EdgeEndo Team Up To Develop New Microfluidic Irrigation Device For Endodontists

Share:
BIOLASE, EdgeEndo Team Up To Develop New Microfluidic Irrigation Device For Endodontists
  • BIOLASE Inc (NASDAQ: BIOL) and EdgeEndo have announced the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device for endodontists.
  • This new Microfluidic Irrigation device is being developed to offer a solution for endodontists, seeking more from their current cleaning and disinfection techniques, such as sodium hypochlorite, ethylenediaminetetraacetic acid, chlorhexidine, or 2-in-1 or 3-in-1 irrigation solutions.
  • BIOLASE anticipates submitting a premarket notification to the FDA in the second quarter of 2021.
  • "This allows BIOLASE to focus its commercial channels on other specialties, such as periodontics and pediatrics, in addition to the approximately 200,000 general dentists in the United States. We look forward to a long and beneficial relationship with EdgeEndo," BIOLASE President and CEO John Beaver said.
  • Price Action: BIOL shares are up 5.2% at $0.74 in market trading hours on the last check Tuesday.
 

Related Articles (BIOL)

View Comments and Join the Discussion!

Posted-In: Briefs EndodontistsNews Penny Stocks Health Care FDA General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com